Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from TNF Pharmaceuticals ( (TNFA) ) is now available.
On March 6, 2025, TNF Pharmaceuticals held a telephonic conference call to discuss the progress of their lead compound, Isomyosamine. The company provided updates on their research and development efforts, but emphasized that the information shared is not necessarily material or required to be disclosed under regulatory obligations.
More about TNF Pharmaceuticals
TNF Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the research and development of medical compounds, with a primary emphasis on their lead compound, Isomyosamine.
YTD Price Performance: -67.83%
Average Trading Volume: 537,931
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $1.02M
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.